Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of EG-1962 versus oral nimodipine in adults with aneurysmal subarachnoid hemorrhage
2015-005033-53Phase 3Completed
- Sponsor
- Edge Therapeutics
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing EG-1962 arm with Oral nimodipine standard-of-care arm (2 arms). Started Sep 2016; status: completed.
02
Drugs
EG-1962nimodipine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2015-005033-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005033-53.